Indivior PLC INDV

LON: INDV | ISIN: GB00BN4HT335 30/04/2025

851,00 GBX (-0,87%)

(-0,87%) 30/04/2025

Grafiek Indivior PLC

Grafiek Indivior PLC

1 dag1d -0,87%
1 week1w 10,23%
1 maand1m 15,16%
3 maanden3m -9,71%
6 maanden6m 19,94%
1 jaar1j -40,41%
5 jaar5j 256,07%

Indivior PLC in het nieuws

Toon enkel gratis nieuws

24 april 2025 · Indivior Announces Q1 2025 Financial Results · Persbericht

4 maart 2025 · Indivior Announces Further Changes to Board of Directors · Persbericht

13 september 2024 · Indivior PLC Sued for Securities Law Violations - Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV · Persbericht

12 september 2024 · INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit · Persbericht

10 september 2024 · Indivior PLC Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV · Persbericht

7 september 2024 · INDV Investors Have Opportunity to Lead Indivior PLC Securities Fraud Lawsuit · Persbericht

6 september 2024 · Shareholders of Indivior PLC Should Contact Levi & Korsinsky Before October 1, 2024 to Discuss Your Rights - INDV · Persbericht

4 september 2024 · Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder · Persbericht

4 september 2024 · Indivior Provides Update on Aelis Farma's Clinical Phase 2B Study Results with AEF0117 in Participants with Cannabis Use Disorder · Persbericht

3 september 2024 · Contact Levi & Korsinsky by October 1, 2024 Deadline to Join Class Action Against Indivior PLC(INDV) · Persbericht

Profiel Indivior PLC

Farmaceutische producten: Andere

Gezondheidstechnologie

Medicinale en botanische productie

CEO: Shaun Thaxter

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe